Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV HCV genotype IV IV infected patients

Wang Bin‐Qiao; Wang Yong‐Lin; Shi Ke‐Qing

首页> 外文期刊>Liver international : >Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV HCV genotype IV IV infected patients

【24h】

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV HCV genotype IV IV infected patients

机译：现实生活中埃及埃及疗效和安全性的疗效和安全性HCV HCV基因型IV IV感染患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Liver international :》 |2017年第5期|共1页
作者
Wang Bin‐Qiao; Wang Yong‐Lin; Shi Ke‐Qing;
展开▼
作者单位

Department of GynecologyWenzhou Medical UniversityWenzhou Zhejiang China;

Department of Infectious DiseasesWenzhou Medical UniversityWenzhou Zhejiang China;

Department of Infectious DiseasesWenzhou Medical UniversityWenzhou Zhejiang China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV HCV genotype IV IV infected patients [J] . Eletreby Rasha, Elakel Wafaa, Said Mohamed, Liver international : . 2017,第4期

机译：现实生活埃及埃及疗效和安全的体验，Simeprevir / Sofosbuvir治疗疗法治疗慢性HCV HCV基因型IV IV感染患者
2. Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV HCV genotype IV IV infected patients [J] . Wang Bin‐Qiao, Wang Yong‐Lin, Shi Ke‐Qing Liver international : . 2017,第5期

机译：现实生活中埃及埃及疗效和安全性的疗效和安全性HCV HCV基因型IV IV感染患者
3. Response to Real life Egyptian experience of?efficacy / safety of Simeprevir Sofosbuvir in HCV HCV genotype? IV IV [J] . Eletreby Rasha, Elakel Wafaa, El Raziky Maissa, Liver international : . 2017,第5期

机译：对现实生活埃及经验的回应？SIMEPREVIR Sofosbuvir在HCV HCV基因型中的功效/安全？ IV IV.
4. Efficacy of combination therapy of interferon-α and ribavirin for HIV/HCV co-infected patients in a six-year follow-up [C] . AiPing Wang, ChunYang Wen, Fang Gao 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：六年随访中干扰素-α和利巴韦林联合治疗对HIV / HCV合并感染患者的疗效
5. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
6. Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort [O] . Anne Laurain, Sophie Metivier, Georges Haour, 2019

机译：simeprevir-sofosbuvir组合在法国ANRS CO22嗜血者队列的HCV基因型1和4单感染患者中的安全性和有效性
7. A Real Life Study on Treatment of Egyptian Patients with HCV Genotype IV with Simeprevir and Sofosbuvir [O] . A. Hanno, D. Elwazzan, M. Ibrahim, 2016

机译：埃及HCV基因型IV与Simeprevir和Sofosbuvir治疗埃及患者的真实研究

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV HCV genotype IV IV infected patients

著录项

引文网络

相似文献

相关主题

期刊订阅